CGTX - Company ID 0001455365
COGNITION THERAPEUTICS INC trades as CGTX. This page tracks COGNITION THERAPEUTICS INC through 289 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-21 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-05-07 |
| Insider trade | 4 | 2026-05-04 |
| Annual report to shareholders | ARS | 2026-04-27 |
| Proxy materials | DEFA14A | 2026-04-27 |
| Proxy statement | DEF 14A | 2026-04-27 |
| Insider trade | 4 | 2026-04-20 |
The largest companies sharing COGNITION THERAPEUTICS INC's SEC industry classification (biological products, (no diagnostic substances)).
In its latest fiscal year COGNITION THERAPEUTICS INC reported a net loss of $23.49M.